Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic Leukemia

References

• Warrell, R.P. Jr. (1996) "Pathogenesis and management of acute promyelocytic leukemia", Annu. Rev. Med., 47, 555–565.
   Google Scholar
• Fenawc, P., Chomienne, C. and Degos, L. (1997) "Acute promyelocytic leukemia: Biology and treatment", Semin. Oncol., 24, 92— 102.
   Google Scholar
• Lo Coco, F., Nervi, C., Avvisati, G. and Mandelli, F. (1998) "Acute promyelocytic leukemia: A curable disease", Leukemia, 12, 1866 — 1880.
   Google Scholar
• Chou, W.C., Tang, J.L., Yao, M., Liang, Y.J., Lee, F.Y., Lin, M.T., et al. (1997) "Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: A high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment", Leukemia, 11, 921–928.
   Google Scholar
• Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., etal. (1999) "A randomized comparison of ATRA followed by chemotherapy and ATRA plus chemotherapy, and the role of maintenance therapy in newly diagnosed acute promyelocy-tic leukemia", Blood, 94, 1192— 1200.
   Google Scholar
• Tallman, M.S., Andersen, J.W., Schiffer, CA., Appelbaum, FR., Feusner, J.H., Ogden, A., et al. (1997) "All-trans retinoic acid in acute promyelocytic leukemia", N. Engl. J. Med., 337, 1021–1028.
   Google Scholar
• Asou, N., Adachi, K., Tamura, J., Kanamaru, A., Kageyama, S., Hiraoka, A., et al. (1998) "Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy: Japan Adult Leukemia Study Group", J. Clin. Oncol., 16, 78–85.
   Google Scholar
• Burnett, AK., Grimwade, D., Solomon, E., Wheatley, K. and Goldstone, A.H. (1999) "Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promye-locytic leukemia treated with all-trans retinoic acid: Results of the Randomized MRC trial", Blood, 93, 4131 —4143.
   Google Scholar
• Ferrara, F., Morabito, F., Martino, B., Specchia, G., Liso, V., Nobile, F., et al. (2000) "CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans retinoic acid and chemother-apy", J. Clin. Oncol., 18, 1295 — 1300.
   Google Scholar
• Bear, MR., Stewart, C.C., Lawrence, D., Arthur, D.C., Byrd, J.C., Davey, FR., et al. (1997) "Expression of the neural adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)", Blood, 90, 1643 — 1648.
   Google Scholar
• Murray, C.K., Estey, E., Paietta, E., Howard, R.S., Edenfield, W.J., Pierce, S., et al. (1999) "CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?", J. Clin. Oncol., 17, 293–297.
   Google Scholar
• Di Bona, E., Sartori, R., Zambello, R., Guercini, N., Madeo, D. and Rodeghiero, F. (2002) "Prognostic significance of CD56 antigen expression in acute leukemia", Hematologica, 87, 250–256.
   Google Scholar
• Byrd, J.C., Weiss, R.B., Arthur, D.C., Lawrence, D., Baer, MR., Davey, F., et al. (1997) "Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461", J. Clin. Oncol., 15, 466–475.
   Google Scholar
• Byrd, J.C., Edenfield, W.J., Shields, D.S. and Dawson, N.A. (1995) "Extramedullary myeloid tumors in acute nonlymphocytic leuke-mia: A clinical review", J. Clin. °ilea, 13, 1800— 1816.
   Google Scholar
• Tallman, M.S., Hakimian, D., Shaw, J.M., Lissner, G.S., Russell, E.J. and Variakojis, D. (1995) "Granulocytic sarcoma is associated with the t(8;21) translocation in acute myeloid leukemia", J. Clin. Oncol., 11, 690–697.
   Google Scholar
• Seymour, J.F., Pierce, S.A., Kantarjan, H.M., Keating, M.J. and Estey, E.H. (1994) "Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56)", Leukemia, 8, 823 — 826.
   Google Scholar
• Liso, V., Specchia, G., Pogliani, EM., Palumbo, G., Mininni, D., Rossi, V., et al. (1998) "Extramedullary involvement in patients with acute promyelocytic leukemia", Cancer, 83, 1522— 1528.
   Google Scholar
• Guglielmi, C., Wartelli, M.P., Diverio, D., Fenu, S., Vegna, ML., Cantu-Rajnoldi, A., et al. (1998) "Immunophenotype of adult and childhood acute promyelocytic leukemia: correlation with morphol-ogy, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases", Br. J. Haematol., 102, 1035 — 1041.
   Google Scholar
• Piedras, J., Lopez-Karpovitch, X. and Cardenas, R. (1998) "Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant", Cytometry, 32, 286–290.
   Google Scholar
• Exner, M., Thalhammer, R., Kapiotis, S., Mitterbauer, G., Knobl, P., Haas, 0.A., et al. (2000) "The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?", Cytometry, 42, 106–109.
   Google Scholar
• Edward, R.H., Wasik, M.A., Finan, J., Rodriguez, R., Moore, J., Kamoun, M., et al. (1999) "Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia", Am. J. Clin. Pathol., 112, 819–827.
   Google Scholar
• Ito, S., Sugawara, T., Enomoto, S., Ono, Y., Numaoka, H., Utsugisawa, T., et al. (2002) "Clonal evolution of blasts in an elderly patient with CD56 ± relapsed acute promyelocytic leuke-mia", Am. J. Hematol., 69, 59–63.
   Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, MT., Flandrin, G., Galton, D.A.G., Gralnick, H.R., et al. (1985) "Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group", Ann. Intern. Med., 103, 620— 625.
   Google Scholar
• Ito, S., Ishida, Y., Murai, K. and Kuriya, S. (2001) "Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome", Leuk. Res., 25, 205 — 211.
   Google Scholar
• Byrd, J.C., Weiss, R.B., Arthur, D.C., Lawrence, D., Baer, MR., Davey, F., et al. (1997) "Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from Cancer and Leukemia Group B 8461", J. Clin. °ilea, 15, 466–475.
   Google Scholar
• Cheson, B.D., Cassileth, PA., Head, DR., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., et al. (1990) "Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia", J. Clin. °ma, 8, 813–819.
   Google Scholar
• Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observation", J. Am. Stat. Assoc., 53, 457–481.
   Google Scholar
• Estey, E., Thall, P.F., Pierce, S., Kantarjian, H. and Keating, M. (1997) "Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine", J. Clin. °ma, 15, 483–490.
   Google Scholar
• Vahdat, L., Maslak, P., Miller, W.H. Jr., Eardley, A., Heller, G., Scheinberg, D.A., etal. (1994) "Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid", Blood, 84, 3843–3849.
   Google Scholar
• Slack, J.L., Arthur, D.C., Lawrence, D., Mrozek, K., Mayer, R.J., Davey, FR., et al. (1997) "Secondary cytogenetic changes in acute promyelocytic leukemia: Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene-A Cancer and Leukemia Group B study", J. Clin. °ilea, 15, 1786— 1795.
   Google Scholar
• Daniels, J.T., Davis, B.J., Houde-McGrail, L. and Byrd, J.C. (1999) "Clonal selection of CD56 ± t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?", Br. J. Haematol., 107, 381–383.
   Google Scholar
• Gallagher, RE., Yeap, BY., Bi, W., Livak, K.J., Beaubier, N., Rao, S., et al. (2003) "Qantitative real-time RT-PCR analysis of PML-RARa mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129", Blood, 101, 2521 — 2528.
   Google Scholar
• Suzuki, R., Yamamoto, K., Seto, M., Kagami, Y., Ogura, M., Yatabe, Y., et al. (1997) "CD7 ± and CD56 ± myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity", Blood, 90, 2417–2428.
   Google Scholar
• Scott, A.A., Head, DR., Kopecky, K.J., Appelbaum, FR., Theil, KS., Greyer, MR., et al. (1994) "HLA-DR, CD33, CD56, CD16 — myeloid/natural killer cell acute leukemia: a previous unrecognized form of acute leukemia potentially misdiagnosed as French—American—British acute myeloid leukemia-M3", Blood, 84, 244–255.
   Google Scholar